Category Archives: Mesenchymal Stem Cells

Asymmetrex Technologies For Stem Cell Medicine. By: Asymmetrex … Continue reading →

Boston, MA (PRWEB) December 04, 2014 In a new report published in the online journal Cell Death and Disease, the Adult Stem Cell Technology Center, LLC (ASCTC) continues to demonstrate its special expertise in uncovering unknown properties that are unique to adult tissue stem cells. In particular, the new study continues to build the companys portfolio of technologies that make previously invisible adult stem cells not only identifiable, but also countable. The studies were performed with mouse hair follicle stem cells. Because of the universal nature of adult tissue stem cell properties, the new findings are predicted to apply to stem cells in a wide range of human tissues as well. For the past half century since the experimental demonstration of their existence, it has not been possible to identify adult tissue stem cells exclusive of other related cell types. Consequently, counting them has been impossible, too. Established stem cell therapies like bone marrow transplantation are suboptimal because of this limitation; and the current worldwide flood of thousands of clinical trials of tissue stem cell transplantation therapies has the same problem. Without being able to count potentially curative adult tissue stem cells, there is no way to optimize and standardize … Continue reading →

Stem Cell Therapy | platelet rich fibrin glue stem cells http://www.arthritistreatmentcenter.com Glue as part of stem cell therapy next Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects Hal... By: Nathan Wei … Continue reading →

Stem cells offer great potential in biomedical engineering due to their pluripotency, which is the ability to multiply indefinitely and also to differentiate and develop into any kind of the hundreds of different cells and bodily tissues. But the precise complexity of how stem cell development is regulated throughout states of cellular change has been difficult to pinpoint until now. By using powerful new single-cell genetic profiling techniques, scientists at the Wyss Institute for Biologically Inspired Engineering and Boston Children's Hospital have uncovered far more variation in pluripotent stem cells than was previously appreciated. The findings, reported today in Nature, bring researchers closer to a day when many different kinds of stem cells could be leveraged for disease therapy and regenerative treatments. "Stem cell colonies contain much variability between individual cells. This has been considered somewhat problematic for developing predictive approaches in stem cell engineering," said the study's co-senior author James Collins, Ph.D., who is a Wyss Institute Core Faculty member, the Henri Termeer Professor of Medical Engineering & Science at MIT, and a Professor of Biological Engineering at MIT. "Now, we have discovered that what was previously considered problematic variability could actually be beneficial to our ability to precisely … Continue reading →

Posted by Dana Sparks (@danasparks) 3 day(s) ago Uniting the Global Stem Cell Community The World Stem Cell Summit, December 3-5 in San Antonio, unites and educates the global stem cell community. With more than 1,200 attendees from more than 40 countries, the annual World Stem Cell Summits interdisciplinary agenda explores disease updates, research directions, cell standardization, regulatory pathways, reimbursements, financing, venture capital and economic development. Throughout the week, the Mayo Clinic Center for Regenerative Medicine will use social media to connect using the hashtag #WSCS14. At the end of the week, we'll let the tweets, Google+ posts, Flickr photos, Facebook posts and YouTube videos tell the story. The World Stem Cell Summit includes in-depth programming and more than 200 international speakers, including leaders from theMayo Clinic Center for Regenerative Medicine: About the World Stem Cell SummitMayo Clinic, The University of Texas Health Science Center at San Antonio, Kyoto University Institute for Integrated Cell-Material Sciences (iCeMS), BioBridge Global, Baylor College of Medicine and the Regenerative Medicine Foundation have joined the Genetics Policy Institute to organize the10th Annual World Stem Cell Summit the largest and most comprehensive multi-track interdisciplinary stem cell conference. Related LinksMayo Clinic at World Stem Cell Summit 2013Mayo … Continue reading →

Cordlife Medical Philippines Inc. (Cordlife), a fully owned subsidiary of Cordlife Group Ltd., a Singapore Exchange mainboard-listed consumer healthcare company catering to the mother and child segment, recently opened its newly upgraded stem cell processing and cryopreservation facility at UP-Ayalaland Technohub in Quezon City. This expansion came less than five years from the opening of its facility in the country and was mainly driven by the growing number of parents who recognize the value of banking here their babys stem cells. The event launch held at Crowne Plaza in Ortigas was hosted by popular DJ Delamar Arias and graced by celebrity moms, actress and beauty queen Lara Quigaman and journalist Nia Corpuz. Delamar, Lara and Nia all shared their personal experiences of being Cordlife moms themselves. Also in attendance to underscore Cordlifes commitment to Filipino parents and their children were Cordlife Group CEO Jeremy Yee, Cordlife Philippines medical director Dr. Arvin Faundo and Cordlife Philippines director Michael Arnonobal. The event highlighted the five essentials of mother and child that Cordlife addresses through services. These essentials are security, expertise, investment, bond and value for life. With the newly upgraded stem cell facility that can accommodate up to 30,000 cord blood and … Continue reading →

- As improved R&D climate supports development, stem cell therapeutics market expected to boom globally KUALA LUMPUR, Malaysia, Dec. 2, 2014 /PRNewswire/ -- Stem cells have the potential to transform healthcare by enabling the cost-effective treatment of many conditions that currently have poor treatment options. This will be particularly important for the rapidly growing aged population as well as the rising proportion of patients with neurological and chronic conditions. Stem cells may enable regenerative treatments that avoid traditional drugs, devices and surgery for these patient groups. New analysis from Frost & Sullivan, Analysis of the Global Stem Cell Market, finds that the market earned revenues of US$40.01 billion in 2013 and estimates this to nearly triple to US$117.66 billion in 2018 at a compound annual growth rate of 24.1 percent. The study covers human adult and embryonic stem cells. While North America is the market leader with more than half of the global stem cell market share, the Asia-Pacific is expected to record the highest compound annual growth rate (CAGR) during the forecast period. In fact, the APAC stem cell market, which was valued at US$5.60 billion in 2013, is projected to increase to US$18.71 billion by 2018. For complimentary … Continue reading →

MIAMI (PRWEB) December 01, 2014 GlobalStemCellsGroup.com has announced plans to team with Portal Medestetica, the largest physician portal in Lain America, to launch Portalstemcells.com, a new portal dedicated to providing physicians in Spain and Latin America with relevant information, clinical research news and products relating to stem cells and regenerative medicine. The new collaboration between Global Stem Cells Group and Portal Medestetica will answer a growing need to expand the reach of high-impact news, studies and breakthroughs, and significantly advance the clinical utilization of stem cell research and clinical trials throughout Latin America. The Portalstemcells.com site is designed to help promote the latest state-of-the-art developments in regenerative medicine as they become available, and to share educational content with physicians throughout the region. Portalstemcells.com will be the ideal vehicle to promote education and cutting-edge science throughout the region, says Ricardo de Cubas, founder of Global Stem Cells Group. The potential of regenerative medicine and stem cells therapies inspiring the medical community to find real opportunities to repair or replace tissue damaged from disease, relieve pain and provide the potential for curing chronic diseases where no cure existed before. The Portalstemcells.com site is aimed at fostering growth and ethical development in the … Continue reading →

Stem Cell Therapy Skin Repair, Anti Aging and Anti Wrinkle Cream - As Seen On Tv - Look Younger http://www.ReadTheReviewsFirst.com Truvisage Anti-Aging Skin Care System Free Trial. By: Greg Smith … Continue reading →

DUBAI, December 1, 2014 /PRNewswire/ -- The Karolinska Institutet Professor Olle Ringdn, who is also the medical director at the Center for Allogeneic Stem Cell Transplantation at the Huddinge University Hospital in Stockholm, is a co-winner of the Hamdan Award for Medical Research Excellence, in the topic of Cell Therapy, sharing the prestigious Award with the American Professor Carl June. (Photo: http://photos.prnewswire.com/prnh/20141201/719718 ) At a grand ceremony, H.H. Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and the Patron of the Award will honor the Swedish Professor Ringdn alongside with 18 other winners of various categories of this Award at its 8th term (2013-2014). Prof. Ringden devoted his life to treating patients with various life-threatening disorders. By endless hard work during four decades, he has substantial discoveries in a variety of research fields that led to decreased transplantation-related mortality and improved survival. He established a stem cell research laboratory, where he, amongst other achievements, pioneered allogenic hematopoetic stem cell transplantation research in Sweden. He conducted various comprehensive studies of the immune system, thus uncovering the compartmentalization of this system. Subsequent to his work, spleen cells are routinely used for immunological testing of deceased organ … Continue reading →